These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 12454376)

  • 1. Plasma lipids and blood fluidity in patients with polygenic hypercholesterolaemia treated with fluvastatin.
    Piñon F; Merino JF; Ferrer JC; Martínez M; Vayá A; Aznar J
    Clin Hemorheol Microcirc; 2002; 27(3-4):193-9. PubMed ID: 12454376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide.
    Romano M; Mezzetti A; Marulli C; Ciabattoni G; Febo F; Di Ienno S; Roccaforte S; Vigneri S; Nubile G; Milani M; Davì G
    J Investig Med; 2000 May; 48(3):183-9. PubMed ID: 10822898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of an indirect effect model to describe the LDL cholesterol-lowering effect by statins in hypercholesterolaemic patients.
    Faltaos DW; Urien S; Carreau V; Chauvenet M; Hulot JS; Giral P; Bruckert E; Lechat P
    Fundam Clin Pharmacol; 2006 Jun; 20(3):321-30. PubMed ID: 16671968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of fluvastatin therapy on plasma interleukin-10 levels in patients with chronic heart failure.
    Tekin A; Sezgin N; Katircibaşi MT; Tekin G; Cölkesen Y; Sezgin AT; Müderrisoğlu H
    Coron Artery Dis; 2008 Nov; 19(7):513-9. PubMed ID: 18923248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of statins on oxidative stress.
    Yilmaz MI; Baykal Y; Kilic M; Sonmez A; Bulucu F; Aydin A; Sayal A; Kocar IH
    Biol Trace Elem Res; 2004 May; 98(2):119-27. PubMed ID: 15073410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of simvastatin and fluvastatin on plasma fibrinogen levels in patients with primary hypercholesterolemia.
    Okopień B; Krysiak R; Madej A; Belowski D; Zieliński M; Kowalski J; Herman ZS
    Pol J Pharmacol; 2004; 56(6):781-7. PubMed ID: 15662091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and pharmacology of fluvastatin.
    Jokubaitis LA
    Br J Clin Pract Suppl; 1994 Dec; (77):11-5. PubMed ID: 19489169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial.
    Liem AH; van Boven AJ; Veeger NJ; Withagen AJ; Robles de Medina RM; Tijssen JG; van Veldhuisen DJ;
    Int J Cardiol; 2004 Feb; 93(2-3):175-9. PubMed ID: 14975544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S; Gamez R; Mas R; Goicochea E
    Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
    Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy.
    Buemi M; Allegra A; Corica F; Aloisi C; Giacobbe M; Pettinato G; Corsonello A; Senatore M; Frisina N
    Clin Pharmacol Ther; 2000 Apr; 67(4):427-31. PubMed ID: 10801253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of fluvastatin on plasma adiponectin levels in dyslipidaemia.
    Sonmez A; Dogru T; Tasci I; Yilmaz MI; Pinar M; Naharci I; Bingol N; Kilic S; Demirtas A; Bingol S; Ozgurtas T; Erikci S
    Clin Endocrinol (Oxf); 2006 May; 64(5):567-72. PubMed ID: 16649978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluvastatin reduces oxidative stress, decreases serum monocyte chemotactic protein-1 level and improves endothelial function in patients with hypercholesterolemia.
    Leu HB; Wu CC; Wu TC; Lin SJ; Chen JW
    J Formos Med Assoc; 2004 Dec; 103(12):914-20. PubMed ID: 15624040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of statins on restenosis after coronary stent implantation.
    Kamishirado H; Inoue T; Sakuma M; Tsuda T; Hayashi T; Takayanagi K; Node K
    Angiology; 2007; 58(1):55-60. PubMed ID: 17351158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers.
    Yasue H; Mizuno Y; Harada E; Itoh T; Nakagawa H; Nakayama M; Ogawa H; Tayama S; Honda T; Hokimoto S; Ohshima S; Hokamura Y; Kugiyama K; Horie M; Yoshimura M; Harada M; Uemura S; Saito Y;
    J Am Coll Cardiol; 2008 May; 51(18):1742-8. PubMed ID: 18452779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluvastatin as co-medication in heart transplant recipients with elevated creatine-kinase.
    Sadoni S; Kaczmarek I; Delgado O; Schmöckel M; Reichart B; Meiser B
    Transplant Proc; 2007 Mar; 39(2):558-9. PubMed ID: 17362781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA
    Br J Clin Pract Suppl; 1994 Dec; (77):28-32. PubMed ID: 19496270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.